We are pleased to announce that Jennifer Che, Managing Director of Eagle IP, was a featured panelist at the annual Fordham Intellectual Property Law & Policy Conference held recently in New York City.

Widely regarded as one of the most prestigious gatherings in the IP world, the Fordham Conference brings together judges, practitioners, and policymakers from across the globe to discuss the most pressing issues in the field. Jennifer contributed her expertise to the China panel, where she engaged in a deep-dive discussion regarding the rapidly shifting intellectual property landscape in the region.

At Eagle IP, we remain committed to staying at the forefront of international IP policy. Jennifer’s participation in this high-level forum underscores our dedication to providing our clients with the most current and sophisticated counsel for their global IP portfolios.

Our Past Events

Recommended Insights

Breaking: China Released Drug Trial Data Protection Implementation Measures

22 May 2026
On May 15, 2026, China’s National Medical Products Administration (NMPA) officially announced the final Measures for the Implementation of Drug Trial Data Protection (“Measures”), effective May 15, 2026. These Measures provide important details supporting the recently announced Implementing Regulations of the Drug Administration Law (“Regulations” – also effective May 15, 2026), which formally introduced a […]

Compositions Limited by Use: A Cautionary Tale

26 October 2022
Section 4.2.3, Part II Chapter 10 of the CNIPA’s Examination Guidelines (“Guidelines”) stipulates that if the specification only discloses one property or use of a composition, the composition claim shall be drafted as a “composition limited by the function or the use”. Furthermore, it specifically states that “most pharmaceutical claims shall be drafted as claims […]
Tapentadol.svg

Polymorph Patents in China: What is the Standard for Inventiveness for New Crystal Forms?

14 July 2020
This case is focused on polymorphs, namely what are the standards for novelty and inventiveness when it comes to new crystal forms of a known drug? A recent Supreme People’s Court decision in China is illustrative of the way Chinese courts are thinking about polymorph patents in China. Grünenthal is a German pharmaceutical company and […]

A More Detailed Overview of China’s Patent Term Extension (PTE) System

17 June 2024
Although PTE has been in the Chinese Patent Law since the 4th Amendment of the law came into effect June 1, 2021, we didn’t really know the exact details of how it operated until the Implementation Regulations and Examination Guidelines (“Implementation Regulations”) were finally released in December 2023. New Rules 77-84 in the Implementation Regulations […]
Top crossarrow-right